Development of a Biomarker Panel to Distinguish Risk of Progressive Chronic Kidney Disease

Chronic kidney disease (CKD) patients typically progress to kidney failure, but the rate of progression differs per patient or may not occur at all. Current CKD screening methods are sub-optimal at predicting progressive kidney function decline. This investigation develops a model for predicting pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Owens, Evan, Tan, Ken-Soon, Ellis, Robert, Del Vecchio, Sharon, Humphries, Tyrone, Lennan, Erica, Vesey, David, Healy, Helen, Hoy, Wendy, Gobe, Glenda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764886/
https://www.ncbi.nlm.nih.gov/pubmed/33327377
http://dx.doi.org/10.3390/biomedicines8120606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764886/
https://www.ncbi.nlm.nih.gov/pubmed/33327377
http://dx.doi.org/10.3390/biomedicines8120606

Ejemplares similares